{"id":"https://openalex.org/W2948801698","doi":"https://doi.org/10.2337/db19-1210-p","title":"1210-P: Pooled Analysis of the Safety and Efficacy of Ertugliflozin in the Elderly","display_name":"1210-P: Pooled Analysis of the Safety and Efficacy of Ertugliflozin in the Elderly","publication_year":2019,"publication_date":"2019-06-01","ids":{"openalex":"https://openalex.org/W2948801698","doi":"https://doi.org/10.2337/db19-1210-p","mag":"2948801698"},"language":"en","primary_location":{"id":"doi:10.2337/db19-1210-p","doi":"https://doi.org/10.2337/db19-1210-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db19-1210-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059098934","display_name":"Richard E. Pratley","orcid":"https://orcid.org/0000-0002-2912-1389","observed_orcids":["https://orcid.org/0000-0002-2912-1389"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"RICHARD E. PRATLEY","raw_affiliation_strings":["Orlando, FL, Memphis, TN, Nantes, France, Kenilworth, NJ, Groton, CT, New York, NY, Andover, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orlando, FL, Memphis, TN, Nantes, France, Kenilworth, NJ, Groton, CT, New York, NY, Andover, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033587716","display_name":"Samuel E. Dagogo-Jack","orcid":"https://orcid.org/0000-0001-5318-9677","observed_orcids":["https://orcid.org/0000-0001-5318-9677"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"SAMUEL DAGOGO-JACK","raw_affiliation_strings":["Orlando, FL, Memphis, TN, Nantes, France, Kenilworth, NJ, Groton, CT, New York, NY, Andover, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orlando, FL, Memphis, TN, Nantes, France, Kenilworth, NJ, Groton, CT, New York, NY, Andover, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025169113","display_name":"Bernard H. Charbonnel","orcid":"https://orcid.org/0000-0002-2117-9279","observed_orcids":["https://orcid.org/0000-0002-2117-9279"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"BERNARD CHARBONNEL","raw_affiliation_strings":["Orlando, FL, Memphis, TN, Nantes, France, Kenilworth, NJ, Groton, CT, New York, NY, Andover, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orlando, FL, Memphis, TN, Nantes, France, Kenilworth, NJ, Groton, CT, New York, NY, Andover, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101233077","display_name":"Shrita M. Patel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"SHRITA M. PATEL","raw_affiliation_strings":["Orlando, FL, Memphis, TN, Nantes, France, Kenilworth, NJ, Groton, CT, New York, NY, Andover, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orlando, FL, Memphis, TN, Nantes, France, Kenilworth, NJ, Groton, CT, New York, NY, Andover, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112372060","display_name":"Mary Anne Hickman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MARY A. HICKMAN","raw_affiliation_strings":["Orlando, FL, Memphis, TN, Nantes, France, Kenilworth, NJ, Groton, CT, New York, NY, Andover, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orlando, FL, Memphis, TN, Nantes, France, Kenilworth, NJ, Groton, CT, New York, NY, Andover, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100547295","display_name":"JIE LIU","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JIE LIU","raw_affiliation_strings":["Orlando, FL, Memphis, TN, Nantes, France, Kenilworth, NJ, Groton, CT, New York, NY, Andover, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orlando, FL, Memphis, TN, Nantes, France, Kenilworth, NJ, Groton, CT, New York, NY, Andover, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108392349","display_name":"Lisa C. Tarasenko","orcid":"https://orcid.org/0009-0001-3315-1468","observed_orcids":["https://orcid.org/0009-0001-3315-1468"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"LISA TARASENKO","raw_affiliation_strings":["Orlando, FL, Memphis, TN, Nantes, France, Kenilworth, NJ, Groton, CT, New York, NY, Andover, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orlando, FL, Memphis, TN, Nantes, France, Kenilworth, NJ, Groton, CT, New York, NY, Andover, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109958040","display_name":"Misoo C. Ellison","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MISOO C. ELLISON","raw_affiliation_strings":["Orlando, FL, Memphis, TN, Nantes, France, Kenilworth, NJ, Groton, CT, New York, NY, Andover, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orlando, FL, Memphis, TN, Nantes, France, Kenilworth, NJ, Groton, CT, New York, NY, Andover, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026935251","display_name":"Ira Gantz","orcid":"https://orcid.org/0000-0002-6565-7113","observed_orcids":["https://orcid.org/0000-0002-6565-7113","https://orcid.org/0000-0001-8572-5614"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"IRA GANTZ","raw_affiliation_strings":["Orlando, FL, Memphis, TN, Nantes, France, Kenilworth, NJ, Groton, CT, New York, NY, Andover, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orlando, FL, Memphis, TN, Nantes, France, Kenilworth, NJ, Groton, CT, New York, NY, Andover, MA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000786302","display_name":"Steven G. Terra","orcid":"https://orcid.org/0000-0002-5815-6193","observed_orcids":["https://orcid.org/0000-0002-5815-6193"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"STEVEN G. TERRA","raw_affiliation_strings":["Orlando, FL, Memphis, TN, Nantes, France, Kenilworth, NJ, Groton, CT, New York, NY, Andover, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orlando, FL, Memphis, TN, Nantes, France, Kenilworth, NJ, Groton, CT, New York, NY, Andover, MA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.09785338,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"68","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ertugliflozin","display_name":"ertugliflozin","score":0.9789999723434448},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9940000176429749},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9670000076293945},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.9810000061988831},{"id":"https://openalex.org/keywords/age-subgroup-analysis","display_name":"age subgroup analysis","score":0.5659999847412109},{"id":"https://openalex.org/keywords/hypovolemia","display_name":"hypovolemia","score":0.6100000143051147},{"id":"https://openalex.org/keywords/renal-adverse-events","display_name":"renal adverse effects","score":0.7450000047683716},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9879999756813049},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9490000009536743},{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":0.7620000243186951},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.6620000004768372},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate","display_name":"estimated glomerular filtration rate","score":0.8259999752044678}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8792928457260132},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.6356993913650513},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6348897814750671},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.6010210514068604},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5964402556419373},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.5895116329193115},{"id":"https://openalex.org/C2776307423","wikidata":"https://www.wikidata.org/wiki/Q425027","display_name":"Glimepiride","level":4,"score":0.5554853677749634},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5473508834838867},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.49935293197631836},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4591493010520935},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3874644339084625},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3458423614501953},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.34090185165405273},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2699647545814514},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.2601568400859833},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.08483436703681946},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db19-1210-p","doi":"https://doi.org/10.2337/db19-1210-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db19-1210-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3045474444","https://openalex.org/W2808785036","https://openalex.org/W3174634721","https://openalex.org/W3023840721","https://openalex.org/W2948759159","https://openalex.org/W2809193421","https://openalex.org/W2809227629","https://openalex.org/W4285273525","https://openalex.org/W3159772021","https://openalex.org/W3159566593"],"abstract_inverted_index":{"Ertugliflozin":[0],"(ERTU),":[1],"an":[2],"SGLT2":[3],"inhibitor,":[4],"improves":[5],"glycemic":[6],"control":[7,79,167,195],"in":[8,20,55,96,133,140,150,171,189,227,240],"adult":[9],"patients":[10],"(pts)":[11],"with":[12,16,25,65,120,163,176,223],"T2DM.":[13],"Elderly":[14],"pts":[15,58,112,134,141,172,175,190,228],"T2DM":[17,66],"are":[18,29],"underrepresented":[19],"clinical":[21],"studies,":[22,211],"often":[23],"present":[24],"multiple":[26],"co-morbidities":[27],"and":[28,51,61,116,136,216,230,256,343],"more":[30],"susceptible":[31],"to":[32,90,166],"adverse":[33],"events":[34],"(AEs).":[35],"Pooled":[36],"analyses":[37],"based":[38],"on":[39],"7":[40],"phase":[41],"3":[42,100,209],"studies":[43,102],"from":[44],"the":[45,49,121,208,241],"VERTIS":[46],"program":[47],"evaluated":[48,88],"safety":[50,144],"efficacy":[52],"of":[53,57,99,123,146,159,182,204,233],"ERTU":[54,68,147,164,224,234],"subgroups":[56],"aged":[59,113],"<65":[60,114,135,229],"\u226565":[62,117,191],"years.":[63],"Pts":[64],"received":[67],"(5":[69],"or":[70,78,83],"15":[71],"mg":[72],"\u00b1":[73],"sitagliptin":[74],"[SITA]":[75],"100":[76],"mg)":[77],"(placebo":[80],"[PBO],":[81],"glimepiride":[82],"SITA).":[84],"Safety":[85],"data":[86],"were":[87,109,225],"up":[89],"104":[91],"weeks.":[92,105],"Efficacy":[93,232],"was":[94,148,185],"assessed":[95],"a":[97,156],"subset":[98],"PBO-controlled":[101,210],"at":[103],"26":[104],"Baseline":[106],"(BL)":[107],"characteristics":[108],"similar":[110,149,186],"between":[111],"(n=3605)":[115],"years":[118],"(n=1254),":[119],"exception":[122],"mean":[124],"BL":[125,177],"estimated":[126],"glomerular":[127],"filtration":[128],"rates":[129,219],"(90.2":[130],"mL/min/1.73":[131,138],"m2":[132,139],"71.4":[137],"\u226565).":[142],"The":[143],"profile":[145],"both":[151],"age":[152,198,236],"groups,":[153],"except":[154],"for":[155],"higher":[157],"incidence":[158,181],"volume":[160],"depletion":[161],"AEs":[162,184],"relative":[165],"(2.4%":[168],"vs.":[169,194,221],"1.1%)":[170],"\u226565.":[173,231],"Excluding":[174],"moderate":[178],"renal":[179],"impairment,":[180],"renal-related":[183,205],"across":[187],"groups":[188],"(ERTU":[192],"[0.6%]":[193],"[0.8%]),":[196],"suggesting":[197],"alone":[199],"does":[200],"not":[201],"increase":[202],"risk":[203],"AEs.":[206],"In":[207],"documented":[212],"hypoglycemia":[213,218],"(4.4%":[214],"vs.6.0%)":[215],"severe":[217],"(0.4%":[220],"0.4%)":[222],"comparable":[226],"by":[235],"group":[237],"is":[238],"shown":[239],"Figure.":[242],"Disclosure":[243],"R.E.":[244],"Pratley:":[245],"Consultant;":[246,299,324],"Self;":[247,252,295,300,311,317,325,339,366,374,380,388,394,402,410],"Sanofi":[248],"US.":[249],"Other":[250],"Relationship;":[251],"AstraZeneca,":[253,312,326,340],"Eli":[254,341],"Lilly":[255,342],"Company,":[257,344],"GlaxoSmithKline":[258],"plc.,":[259],"Janssen":[260,264,301,362],"Global":[261],"Services,":[262],"LLC.,":[263],"Research":[265,309],"&":[266,276,305,329,347,368,382,396,404,416],"Development,":[267],"Lexicon":[268],"Pharmaceuticals,":[269,272,302,363],"Inc.,":[270,273,282,284,303,307],"Ligand":[271],"Merck":[274,304,327,345,367,381,395,403,414],"Sharp":[275,328,346,415],"Dohme":[277,330,348,417],"Corp.,":[278,331,349],"Mundipharma,":[279],"Novo":[280,313,332,350],"Nordisk":[281,314,333,351],"Pfizer":[283,375,389,411,419],"Sanofi,":[285,335,353],"Takeda":[286,354],"Development":[287],"Center":[288],"Americas,":[289],"Inc.":[290,298,315,321,364,370,376,384,390,398,406,412,420],"S.":[291],"Dagogo-Jack:":[292],"Board":[293],"Member;":[294],"Jana":[296],"Care":[297],"Co.,":[306,369,383,397,405],"Sanofi-Aventis.":[308],"Support;":[310],"Stock/Shareholder;":[316,360,365],"Dance":[318],"Biopharm":[319],"Holdings":[320],"B.":[322],"Charbonnel:":[323],"A/S,":[334,352],"Servier.":[336],"Speaker's":[337],"Bureau;":[338],"Pharmaceutical":[355],"Company":[356],"Limited.":[357],"S.M.":[358],"Patel:":[359],"Spouse/Partner;":[361],"M.A.":[371],"Hickman:":[372],"Employee;":[373,379,387,393,401,409],"J.":[377],"Liu:":[378],"L.":[385],"Tarasenko:":[386],"M.C.":[391],"Ellison:":[392],"I.":[399],"Gantz:":[400],"S.G.":[407],"Terra:":[408],"Funding":[413],"Corp;":[418]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2019-06-14T00:00:00"}